Pensions, as an accounting and possibly a cash issue, are best kept under the carpet. Two things can wake up that monster: lower risk-free rates that kick future obligations higher…

In this strategy product covering 36 pages, we screen the combined AlphaValue & Baader Helvea coverage universe to identify investment opportunities following the extreme volatilities European equities have lived through…

AlphaValue’s analysts rushed the earnings-cut exercise as businesses dislocate worldwide with the stay-at-home policy. The amazing thing is that some corporates refuse to see the second order impact of the…

Who will be lending? It was clear from late January that the Coronavirus-induced mess was a supply-chain issue and an intercompany credit issue. In China, the true extent of the…

So far the communication from wind OEMs has been to say that it is too early to measure the consequences of the coronavirus on the business. The full impact will…

Amundi and Banco Sabadell have announced an agreement whereby Amundi has purchased the Spanish bank’s AM division. They are also entering into a 10-year strategic partnership for the distribution of…

2019 has been another buoyant year for the payment industry and the fintech industry as a whole. Consolidation or capital raisings have strongly contributed to the headlines while Facebook’s ambition…

Saudi Aramco, the giant state-owned oil company, is now listed since 11/12  on  the Riyadh’s Tadawul Exchange. With only 1.5% up for sale, the IPO raised a jaw-dropping $25.6bn and…

A number of initiatives taken by the Chinese government to strengthen its pharmaceutical sector have started to bear fruit – Beigene’s ‘zanubrutinib’ became the first innovative drug by a Chinese…

Roche is worth €233bn, only second to Nestlé in the European contest for the largest market caps. The six other big Pharma companies (including Bayer) will bring the total sector…